NCT04598048View on ClinicalTrials.gov

Quality of Life Post-ACS in Participants from EMMACE

CompletedOBSERVATIONAL
Enrollment

13,400

Participants

Timeline

Start Date

September 27, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

November 8, 2024

Conditions
Cardiovascular Diseases
Interventions
BEHAVIORAL

Questionnaire

Patients will complete an EQ-5D questionnaire, medication and lifestyle questions

Trial Locations (1)

LS2 9JT

University of Leeds, Leeds

All Listed Sponsors
lead

University of Leeds

OTHER

NCT04598048 - Quality of Life Post-ACS in Participants from EMMACE | Biotech Hunter | Biotech Hunter